|
|||||
|
|
Efficacy and safety of switching to dolutegravir plus emtricitabine/tenofovir disoproxil fumarate (TDF) or elvitegravir/cobicistat/emtricitabine/TDF in virologically suppressed HIV‐infected patients in clinical practice: results from a multicentre,observational study |
|
| Authors: | G Baldin A Ciccullo A Capetti S Rusconi G Sterrantino MV Cossu A Giacomelli F Lagi A Latini P Bagella A De Luca S Di Giambenedetto G Madeddu |
| Abstract: | |
| Keywords: | dolutegravir efficacy elvitegravir/cobicistat/tenofovir/emtricitabine safety tenofovir/emtricitabine |